Geneva, Oct. 8 -- International Clinical Trials Registry received information related to the study (NCT07191561) titled 'Hepatic Lipid Metabolism-Alcohol Use Disorder' on Sept. 24.

Study Type: Observational

Primary Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Condition: Alcohol Use Disorder

Intervention: Diagnostic Test: Liver biopsy

Recruitment Status: Not recruiting

Date of First Enrollment: November 28, 2025

Target Sample Size: 25

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07191561

Published by HT Digital Content Services with permission from Health Daily Digest....